Matinas BioPharma Holdings stock price
마티나스 바이오파머 홀딩스NYSEAMERICAN:MTNB · NYSE Amex · Healthcare · sector #16Today's signals · Near 52-week high, MA aligned
Signal details →Matinas BioPharma Holdings last closed at $3.01 (+6.74%) on 2026-10-06. Signals today: Near 52-week high, MA aligned. Listed on NYSE Amex. Trailing 12 months PER is -0.2×. Its overall grade ranks 691 of 741 stocks in Healthcare.
About this company
Matinas BioPharma Holdings last closed at $3.01 (+6.74%) on 2026-10-06. Signals today: Near 52-week high, MA aligned. Listed on NYSE Amex.
Details →Reported results
Position in sector
Healthcare · Overall F · 691/741
Valuation grade C+
Related stocks
- Astellas PharmaCustomer
MAT2203 공동개발/상업화 관련 주요 파트너로 알려짐
- SandozCustomer
항감염제/제네릭 상업화 협력 가능성이 거론된 제약사
- PfizerCompetitor
항감염·전염병 치료제 시장에서 대형 경쟁사
About Matinas BioPharma Holdings
- What technical signals does Matinas BioPharma Holdings (MTNB) have?
- Matinas BioPharma Holdings current technical signals: MA alignment (score 1.00).
- Is Matinas BioPharma Holdings a cup-and-handle pattern?
- No. Matinas BioPharma Holdings has no valid Cup signal right now.
- What published figures are available for Matinas BioPharma Holdings?
- Market cap: $19.28M. Trailing 12 months PER: -0.2×. Latest quarter PBR: 0.67×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Matinas BioPharma Holdings, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.